Small-cell lung cancer growth inhibition: synergism between NMDA receptor blockade and chemotherapy

BACKGROUND: Small-cell lung cancer (SCLC) has a poor prognosis since there is currently no effective therapy for commonly recurring disease. In our previous study, both primary and recurrent human tumors have been shown to express functional N-methyl-D-aspartate (NMDA) receptors, and blockade of the...

Descripción completa

Detalles Bibliográficos
Autores principales: North, William G, Liu, Fuli, Dragnev, Konstantin H, Demidenko, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350832/
https://www.ncbi.nlm.nih.gov/pubmed/30774453
http://dx.doi.org/10.2147/CPAA.S183885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350832/
https://www.ncbi.nlm.nih.gov/pubmed/30774453
http://dx.doi.org/10.2147/CPAA.S183885

Ejemplares similares